299 related articles for article (PubMed ID: 19710463)
1. Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in mice.
Otten MA; Groeneveld TW; Flierman R; Rastaldi MP; Trouw LA; Faber-Krol MC; Visser A; Essers MC; Claassens J; Verbeek JS; van Kooten C; Roos A; Daha MR
J Immunol; 2009 Sep; 183(6):3980-8. PubMed ID: 19710463
[TBL] [Abstract][Full Text] [Related]
2. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes.
Yang R; Otten MA; Hellmark T; Collin M; Björck L; Zhao MH; Daha MR; Segelmark M
Nephrol Dial Transplant; 2010 Aug; 25(8):2479-86. PubMed ID: 20219834
[TBL] [Abstract][Full Text] [Related]
4. Predominant role of FcgammaRIII in the induction of accelerated nephrotoxic glomerulonephritis.
Fujii T; Hamano Y; Ueda S; Akikusa B; Yamasaki S; Ogawa M; Saisho H; Verbeek JS; Taki S; Saito T
Kidney Int; 2003 Oct; 64(4):1406-16. PubMed ID: 12969160
[TBL] [Abstract][Full Text] [Related]
5. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats.
Kovalenko P; Fujinaka H; Yoshida Y; Kawamura H; Qu Z; El-Shemi AG; Li H; Matsuki A; Bilim V; Yaoita E; Abo T; Uchiyama M; Yamamoto T
Int Immunol; 2004 May; 16(5):625-34. PubMed ID: 15096492
[TBL] [Abstract][Full Text] [Related]
6. Antiglomerular basement membrane nephritis in the mouse. Study on the role of complement in the heterologous phase.
Schrijver G; Assmann KJ; Bogman MJ; Robben JC; de Waal RM; Koene RA
Lab Invest; 1988 Oct; 59(4):484-91. PubMed ID: 3050274
[TBL] [Abstract][Full Text] [Related]
7. Resistance of CD28-deficient mice to autologous phase of anti-glomerular basement membrane glomerulonephritis.
Nitta K; Horita S; Ogawa S; Matsumoto M; Hara Y; Okano K; Hayashi T; Abe R; Nihei H
Clin Exp Nephrol; 2003 Jun; 7(2):104-12. PubMed ID: 14586728
[TBL] [Abstract][Full Text] [Related]
8. Increased susceptibility to immunologically mediated glomerulonephritis in IFN-gamma-deficient mice.
Ring GH; Dai Z; Saleem S; Baddoura FK; Lakkis FG
J Immunol; 1999 Aug; 163(4):2243-8. PubMed ID: 10438967
[TBL] [Abstract][Full Text] [Related]
9. Resistance of Fc receptor- deficient mice to fatal glomerulonephritis.
Park SY; Ueda S; Ohno H; Hamano Y; Tanaka M; Shiratori T; Yamazaki T; Arase H; Arase N; Karasawa A; Sato S; Ledermann B; Kondo Y; Okumura K; Ra C; Saito T
J Clin Invest; 1998 Sep; 102(6):1229-38. PubMed ID: 9739057
[TBL] [Abstract][Full Text] [Related]
10. [Goodpasture's syndrome. Antiglomerular basal membrane antibody-mediated glomerulonephritis].
Pagsberg K; Pedersen G; Hansen FM
Ugeskr Laeger; 1989 Aug; 151(34):2141-4. PubMed ID: 2773147
[TBL] [Abstract][Full Text] [Related]
11. Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficient mice.
Wakayama H; Hasegawa Y; Kawabe T; Hara T; Matsuo S; Mizuno M; Takai T; Kikutani H; Shimokata K
Eur J Immunol; 2000 Apr; 30(4):1182-90. PubMed ID: 10760808
[TBL] [Abstract][Full Text] [Related]
12. [Role of complement in experimental glomerulonephritis].
Parra Borges G; Mosquera J; Rodríguez-Iturbe B
Invest Clin; 1991; 32(2):91-105. PubMed ID: 1807401
[TBL] [Abstract][Full Text] [Related]
13. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
[TBL] [Abstract][Full Text] [Related]
14. Effect of glomerular basement membrane on the initiation of chemiluminescence and lysosomal enzyme release in human polymorphonuclear leucocytes: an in vitro model of glomerular disease.
Davies M; Coles GA; Harber MJ
Immunology; 1984 May; 52(1):151-9. PubMed ID: 6715018
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
16. Histopathology of humorally mediated anti-glomerular basement membrane (GBM) glomerulonephritis in mice.
Le Hir M
Nephrol Dial Transplant; 2004 Jul; 19(7):1875-80. PubMed ID: 15128887
[TBL] [Abstract][Full Text] [Related]
17. Anti-GBM glomerulonephritis: a T cell-mediated autoimmune disease?
Lou YH
Arch Immunol Ther Exp (Warsz); 2004; 52(2):96-103. PubMed ID: 15179323
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A reduces albuminuria in experimental anti-GBM nephritis independently from changes in GFR.
Schrijver G; Assmann KJ; Wetzels JF; Berden JH
Nephrol Dial Transplant; 1995; 10(7):1149-54. PubMed ID: 7478116
[TBL] [Abstract][Full Text] [Related]
19. Different mediator systems in biphasic heterologous phase of anti-GBM nephritis in mice.
Feith GW; Assmann KJ; Bogman MJ; van Gompel AP; Schalkwijk J; Koene RA
Nephrol Dial Transplant; 1996 Apr; 11(4):599-607. PubMed ID: 8671846
[TBL] [Abstract][Full Text] [Related]
20. Intraglomerular basement membrane translocation of immune complex (IC) in the development of passive in situ IC nephritis of rats.
Fujigaki Y; Nagase M; Honda N
Am J Pathol; 1993 Mar; 142(3):831-42. PubMed ID: 8456943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
